Crescent Energy's low P/S ratio may reflect market doubts about future revenue growth, despite industry-aligned expectations. Shareholders may foresee revenue instability, typically a share price support.
71750344 :
Is NIO still a buy? There has been so much dissing of NIO, I can’t figure out why. I own several shares of NIO and watched my successful choice and investment really dwindle in value.
Gainers: •$SailPoint Technologies(SAIL.US)$+30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash) •$Veru Inc(VERU.US)$+28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy) •$Affimed NV(AFMD.US)$+12.9% (Presents Upda...
Crescent Energy股票讨论区
Warren Buffett vs Michael Burry
专栏Today's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More
In reaction to earnings/guidance:
• $Coupa Software(COUP.US)$ +12% (also authorizes new $100mln share repurchase program),$REV Group(REVG.US)$ -5%,$G-III服装集团(GIII.US)$ + 2.1%,$Gitlab(GTLB.US)$ +1.2%
Other news:
• $特百惠(TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $巴西特家具(BSET.US)$ +5% (acqu...
专栏Today's pre-market stock movers: DWAC, GS, MU, EDU and more
• $Day One Biopharmaceuticals(DAWN.US)$ +67.7% (Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma)
• $Gracell Biotechnologies(GRCL.US)$ +12.1% (Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients)
• $iPATH 标普500 VIX短期期货ETN(VXX.US)$ +6...
专栏Today's pre-market stock movers: NIO, XPEV, AAPL, NVDA and more
• $SailPoint Technologies(SAIL.US)$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $Veru Inc(VERU.US)$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $Affimed NV(AFMD.US)$ +12.9% (Presents Upda...
专栏Top upgrades and downgrades on 4/8
• $Afya Ltd(AFYA.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $Appfolio(APPF.US)$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $罗宾逊物流(CHRW.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $Coupang(CPNG.US)$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $Gatos Silver(GATO.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT Inc(ITT.US)$: UBS Upgr...
暂无评论